- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01643057
Stochastic Resonance Mattress (Physiological Interventions) and Biomarkers for Enhancing Neonatal Health
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Apnea of prematurity is defined as cessation of breathing that lasts for more than 20 seconds and/or is accompanied by oxygen desaturation or a decrease in heart rate (bradycardia). Because apnea presents itself within a variety of diseases in newborns, its diagnosis is based largely on the exclusion of other findings. The difficulty in relating the manifestation of apnea to its cause can lead to issues regarding appropriate medical management and delays in treatment.
Our exploration of physiological interventions for Apnea of Prematurity begins with stochastic resonance. Stochastic resonance is the introduction of noise to a system, to alter the system's behavior. This technology has been examined in previous medical applications. The hypothesis for this work is that stochastic resonance stimulation, in the form of gentle vibrations, will stabilize immature breathing patterns in infants.
In this research study, we will use an apnea mattress developed by engineers at the Wyss Institute, Harvard University, which provides gentle vibrations to the infant. We will closely follow the research protocol from UMass Medical School. Whilst the infant is on the mattress, clinical care data will be collected to determine effect on breathing patterns. We also hope to collect enough baseline and intervention data signals to be able to identify candidate biomarkers for apnea. This will assist in development of predictive algorithms for apnea in infants.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Beth Israel Deaconness Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Eligible subjects are infants currently inpatient in the NICU at Beth Israel Deaconess Medical Center and:
- Born premature, at a gestational age < 36 weeks
- Demonstrate irregular breathing by having had at least one documented clinical apnea (> 20 seconds), bradycardia (< 100 bpm) and/or desaturation (< 90%)
Exclusion Criteria:
Eligible infants meeting the inclusion criteria above will be excluded from participation in the study if he/she:
- Is at a Post Conceptual Age of > 45 weeks at time of study (Calculated as: weeks of age at birth + weeks of age since birth)
- Has demonstrable pulmonary disease at time of study, i.e. Chronic Lung Disease, Infant Respiratory Distress Syndrome
- Has Hypoxic-Ischemic Encephalopathy including a cord pH of ≤ 7
- Has a congenital abnormality
- Has a genetic syndrome
- Has an anatomic brain anomaly
- Has hydrocephalus or intraventricular hemorrhage > Grade 3 or 4
- Is anemic (hemoglobin < 8g/dL)
- Has an infection at time of study
- Is undergoing therapeutic hypothermia
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Stochastic Resonance Mattress
The infant's isolette mattress will be replaced with a specially designed mattress (non-commercially available, designed by engineers at the Wyss Institute, Harvard University) to provide gentle vibrations and sounds during mattress stimulations.
|
The infant's isolette mattress will be replaced with a specially designed mattress (non-commercially available, designed by engineers at the Wyss Institute, Harvard University) to provide gentle vibrations and sounds during mattress stimulations.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Investigate effects of mattress intervention on breathing patterns
Time Frame: Each study session may last up to 24 hours. Participants may take part in up to 4 study sessions.
|
Focus on inter-breath intervals and oxygen desaturation.
|
Each study session may last up to 24 hours. Participants may take part in up to 4 study sessions.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Candidate Biomarkers for Apnea of Prematurity
Time Frame: Each study session may last up to 24 hours. Participants may take part in up to 4 study sessions.
|
Candidate biomarkers in cardio-pulmonary, temperature, audiometry, photometry and clinical assessment data.
|
Each study session may last up to 24 hours. Participants may take part in up to 4 study sessions.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Vincent C Smith, MD, MPH, Beth Israel Deaconess Medical Center
- Principal Investigator: David Paydarfar, MD, UMass Medical School
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AMD-CS-0015
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Apnea of Prematurity
-
Uludag UniversityRecruitingApnea of Prematurity | Apnea NeonatalTurkey (Türkiye)
-
Assiut UniversityNot yet recruitingApnea of Prematurity | Preterm Neonates
-
University of California, IrvineActive, not recruiting
-
University of ManitobaCanadian Institutes of Health Research (CIHR); The Children's Hospital Foundation...Completed
-
Children's Hospital of Fudan UniversityCompletedApnea of Prematurity
-
NobelpharmaCompleted
-
Daping Hospital and the Research Institute of Surgery...Unknown
-
Mednax Center for Research, Education, Quality...CompletedApnea of PrematurityUnited States
-
University of MiamiThe Gerber FoundationCompletedApnea of Prematurity | Periodic Breathing | Desaturation of Blood | Central Apnea | Obstructive Apnea of NewbornUnited States
-
Ain Shams UniversityUnknown
Clinical Trials on Stochastic Resonance Mattress
-
University of DelawareCompletedAnkle Sprains | Ankle InstabilityUnited States
-
University of DelawareCompleted
-
University of DelawareParkinson's FoundationCompletedParkinson DiseaseUnited States
-
University of DelawareActive, not recruiting
-
Virginia Commonwealth UniversityCompleted
-
National Yang Ming UniversityTaipei Veterans General Hospital, TaiwanUnknownHealthy | Stroke, IschemicTaiwan
-
Bern University of Applied SciencesGoethe University; Maastricht University Medical Center; Swiss Federal Institute...CompletedDistorted; Balance
-
Bern University of Applied SciencesGoethe University; Maastricht University Medical Center; Swiss Federal Institute...CompletedEquilibration Disorder, Vestibular NerveSwitzerland
-
University of BernCompleted
-
Indonesia UniversityTerramed Physio & Rehab; National Sports Institute MalaysiaCompletedObesity | Knee Osteoarthritis | Balance Board | Stochastic Resonance Therapy-Whole Body VibrationIndonesia